Tekmira Pharmaceuticals Surges 20% Following Clinical Study Update

By: via Benzinga
Shares of Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR) spiked up approximately 20 percent Wednesday following an update from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.